For Investors

Structured diligence on the claims behind an opportunity.

Whether you are screening a new opportunity or supporting a portfolio company, you need to know which claims must be true, what the evidence shows, and where the comparators failed.

BioticaBio runs HDDT diligence — testable claims, support/refute scoring, and comparator failure analysis — then can publish the reviewed conclusion as citation-backed authority for the company.

Why this ICP is most accessible: one engagement scales across an entire portfolio, producing both a decision tool and a durable market-facing asset.

BioticaBio is a diligence service: we run HDDT tests for founders, investors, and scientific organizations, then publish the results as citation-backed authority.

This supports

  • follow-on fundraising
  • strategic partnering
  • company positioning
  • portfolio storytelling
  • diligence readiness
  • investment committee communication

Hypothesis-driven operating model

When the claims behind a company are tested and backed by evidence, the right investors and partners evaluate it faster — and search and AI systems represent it accurately.

HDDT outputs determine SEO and GEO attention allocation: which claims, entities, pages, and prompts are prioritized first based on evidence strength, contradiction risk, and decision relevance.

  1. Decompose the thesis into the specific claims investors need to believe.
  2. Test each claim against the evidence for it, against it, and still missing.
  3. Publish the reviewed conclusion as citation-backed authority.
  4. Measure how investors, partners, and AI systems find and represent it.
Review the HDDT framework →